Growth Metrics

Scholar Rock Holding (SRRK) Other Non-Current Assets (2017 - 2026)

Scholar Rock Holding's quarterly Other Non-Current Assets came in at $3.8 million in Q1 2026, up 58.16% year-on-year from $2.4 million in Q1 2025, and up 530.3% quarter-over-quarter from $604000.0 in Q4 2025.

Scholar Rock Holding has reported Other Non-Current Assets for 10 years, with the latest figure at $3.8 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets rose 58.16% year-over-year to $3.8 million; the trailing twelve-month figure through Mar 2026 stood at $3.8 million (up 58.16% YoY), and the FY2025 full-year result was $604000.0, down 74.91% from the prior year.
  • Other Non-Current Assets for Q1 2026 stood at $3.8 million, up from $604000.0 in the prior quarter.
  • The five-year high for Other Non-Current Assets was $3.8 million in Q3 2025, with the low at $604000.0 in Q4 2025.
  • Average Other Non-Current Assets over 5 years is $2.5 million, with a median of $2.5 million recorded in 2022.
  • Year-over-year, Other Non-Current Assets surged 150.8% in 2022 and slumped 74.91% in 2025.
  • Tracing SRRK's Other Non-Current Assets over 5 years: stood at $2.5 million in 2022, then slipped by 3.64% to $2.4 million in 2023, then changed by 0.0% to $2.4 million in 2024, then tumbled by 74.91% to $604000.0 in 2025, then soared by 530.3% to $3.8 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.8 million (Q1 2026), $604000.0 (Q4 2025), and $3.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 12.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 60,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 1.26 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 2.13 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 63.55 Mn
10 Scholar Rock Holding 500.61 Mn 20.67 Mn - 3.81 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 3.81 Mn
Dec 31, 2025 604,000.00
Sep 30, 2025 3.81 Mn
Jun 30, 2025 2.96 Mn
Mar 31, 2025 2.41 Mn
Dec 31, 2024 2.41 Mn
Sep 30, 2024 2.41 Mn
Jun 30, 2024 2.41 Mn
Mar 31, 2024 2.41 Mn
Dec 31, 2023 2.41 Mn
Sep 30, 2023 2.61 Mn
Jun 30, 2023 2.61 Mn
Mar 31, 2023 2.50 Mn
Dec 31, 2022 2.50 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.50 Mn
Mar 31, 2022 2.50 Mn
Dec 31, 2021 2.50 Mn
Sep 30, 2021 2.50 Mn
Jun 30, 2021 2.50 Mn
Mar 31, 2021 996,000.00
Dec 31, 2020 1.02 Mn
Sep 30, 2020 1.05 Mn
Jun 30, 2020 1.06 Mn
Mar 31, 2020 2.50 Mn
Dec 31, 2019 98,000.00
Sep 30, 2019 85,000.00
Jun 30, 2019 205,000.00
Mar 31, 2019 205,000.00
Dec 31, 2018 205,000.00
Sep 30, 2018 205,000.00
Jun 30, 2018 205,000.00
Dec 31, 2017 50,000.00